The Journal of Translational Medicine has an Impact Factor of 7.5 for 2024.
Based on the official 2024 metrics published by BioMed Central (Springer Nature), this places Journal of Translational Medicine among the leading Q1 journals in fields like experimental medicine and translational biomedicine. Its outstanding 5-year Impact Factor of 7.0, strong SCImago Journal Rank (SJR) of 1.997, and high h‑index of 153 reflect its sustained influence and citation appeal.
The Journal of Translational Medicine (often called BMC Journal of Translational Medicine) has been part of Springer’s BioMed Central since 2003. It’s a fully open-access, peer-reviewed journal (ISSN: 1479‑5876), concentrating on research derived directly from human experimentation, such as early clinical trials and biomarker studies, with the goal of bridging basic lab findings and real-life clinical applications. It publishes continuously—no fixed volume or issue numbers—and brings studies online immediately after acceptance.
You'd expect the usual suspects — oncology, neurology, immunology — and yes, those are there. But JTM also embraces:
Basically, if your research can go from bench to bedside — and maybe even change how we treat people globally — it probably belongs here.
The journal also loves multidisciplinary work. So if you're the oddball working with both CRISPR and wearable biosensors, don't worry. You're in good company.
According to its editorial philosophy, JTM is on a mission to accelerate clinical applications of research. But not just any research — it prioritizes studies with real-world relevance. Think beyond statistical significance. Think patient impact.
And here's the thing: JTM isn’t shy about shaking things up. It actively encourages innovative methodologies, non-traditional study designs, and cross-disciplinary work. If your research challenges old models, this might just be your platform.
The official ISO‑4 abbreviation is J. Transl. Med. —commonly used in citations and indexing systems like PubMed and Web of Science.
Here’s the latest on impact factor and journal ranking:
Other key figures:
BioMed Central does not formally publish acceptance rates, but user reports from platforms like LetPub indicate:
These timelines stem from user-submitted experiences and may not represent every submission.
Key submission points from the journal’s official guidance:
The journal outlines a clear 3‑step process:
So does the Journal of Translational Medicine live up to its reputation? The impact factor around 7.2, Q1 ranking, and h-index of 153 indicate strong scientific influence — especially for translational studies rooted in human data. The review timeline is fast by many standards, even though acceptance rate is unofficial. And with author guidelines aligned to ICMJE, strong data policies, and open-access licensing, it’s clearly structured for transparency and reach.
Tired of sifting through endless papers to find what's relevant? With **PubMed.ai Research Reports**, you can generate structured, AI-powered research summaries in just one click. Whether you're working on checkpoint inhibitors in lung cancer or tracking biomarkers across clinical trials, our smart reports extract the most cited studies, highlight key findings, and organize them into an easy-to-read format—complete with citations.
Read More:
The official abbreviation is J. Transl. Med.
The 2023 impact factor is 7.7, and it is projected to stay in the 7-8 range in 2024. This makes it a high-impact journal in the biomedical field.
Go to the official submission portal and follow the submission checklist. Be sure to adhere closely to the Journal of Translational Medicine author guidelines.
Yes, it is fully indexed in PubMed, Scopus, Web of Science, and other major databases.
JTM accepts original research, reviews, short reports, methodology papers, and editorials. It prioritizes work with a clear translational pathway and real-world clinical relevance.
Have a question about medical research, clinical practice, or evidence-based treatment? Access authoritative, real-time insights: PubMed.ai is an AI-Powered Medical Research Assistant.